You searched for "Glaucoma-NET"
Glaucoma-NET: a novel way of improving glaucoma management in sub-Saharan Africa
1 June 2022
| Fatima Kyari, Affiong Ibanga, Adeola Onakoya, Heiko Philippin, Winifred Nolan, William Dean, Marcia Zondervan, Covadonga Bascaran, Andrew Tatham
|
EYE - Cornea, EYE - General
Background Glaucoma is the second most common cause of blindness worldwide [1]. People with untreated glaucoma suffer from irreversible, progressive loss of sight. The disease is characterised by progressive loss of visual field, with pathological cupping of the optic disc...
BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.
Risk factors and untreated POAG
1 December 2013
| Lorraine North
|
EYE - Glaucoma
The authors examined 50 untreated open angle glaucoma patients to determine if there was an association between the level of glaucomatous damage and documented risk factors. In this study the authors measured the extent of morphologic and functional glaucomatous damage...
The first virtual UKEGS conference will be held on Friday 27 November 2020
22 October 2020
For the first time, the UK and Eire Glaucoma Society (UKEGS) 2020 conference will be hosted digitally in light of the pandemic.
Reproducible OCT RNFL map in unilateral glaucoma
1 April 2015
| Lorraine North
|
EYE - Glaucoma
The aim of the study was to compare the reproducibility of the optical coherence tomography retinal nerve fibre layer (OCT RNFL) thickness map between glaucomatous and fellow normal eyes of unilateral glaucoma patients. The authors carried out a prospective case...
UKEGS (UK and Éire Glaucoma Society) Conference 2025
5 November 2025
-6 November 2025
After a successful conference in Southampton in October 2024, we are thrilled to announce that 2025 UKEGS President, Dr Andrew Tatham, will be hosting the next symposium at the Assembly Rooms in Edinburgh city centre on 5 and 6 November 2025.
Glaucoma UK offers up to £50,000 for the Open Call Research Award 2024
Glaucoma UK accepts applications for the Open Call Research Award 2024, which offers up to £50,000 in funding for glaucoma-related research. This award invites both clinical and non-clinical researchers who aim to enhance our understanding of glaucoma, and improve outcomes for people living with the disease.
Glaucoma diagnosis with spectral-domain OCT of GCL and IPL
1 October 2017
| Chrysostomos D Dimitriou
|
EYE - Glaucoma
This is a prospective, cross-sectional, observational study by the New York Eye and Ear Infirmary, which recruited normal subjects and glaucoma patients with a range of visual field loss representing various degrees of glaucomatous optic neuropathy. A total of 69...
Uveitic glaucoma
1 June 2018
| Nikolaos D Georgakarakos
|
EYE - Glaucoma
The purpose of this retrospective study from two tertiary Institutions in Israel over a period of 13 years, is to present the long-term outcomes of uveitic glaucoma and to identify risk factors for progression. The study included 34 patients (53...
A novel way to diagnose optic neuropathies using Bruch’s membrane opening
7 December 2020
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Glaucomatous neuropathy, compressive optic neuropathy, minimal rim width, non-arteritic anterior ischaemic optic neuropathy, non-glaucomatous neuropathy
Differential diagnosis of optic neuropathies can be challenging but is crucial for the correct management of the underlying disease and prevention of further damage. Bruch’s membrane opening (BMO) was recently discovered as the anatomical border of the optic disc. BMO...
Retinal vessel diameter in pseudoexfoliation
5 February 2020
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
Pseudoexfolation (PEX) is characterised by deposition of fibrillary extracellular material on ocular and extraocular tissue. Studies have shown that deposition in vascular structures cause hypoxia and ischaemia. In the eye, a decrease in blood supply to the optic nerve can...
